Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Ventyx Biosciences, Inc. per 2025 Jun 30 adalah -130.40 MM.
- Nilai net income untuk Ventyx Biosciences, Inc. per 2025 Jun 30 adalah -119.03 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -130.40 | -119.03 | |
2025-03-31 | -136.78 | -123.99 | |
2024-12-31 | -148.45 | -135.12 | |
2024-09-30 | -166.38 | -152.52 | |
2024-06-30 | -185.78 | -171.30 | |
2024-03-31 | -207.21 | -192.60 | |
2023-12-31 | -207.99 | -192.96 | |
2023-09-30 | -196.22 | -181.42 | |
2023-06-30 | -169.69 | -157.86 | |
2023-03-31 | -132.94 | -124.62 | |
2022-12-31 | -113.14 | -108.43 | |
2022-09-30 | -92.39 | -90.98 | |
2022-06-30 | -73.76 | -73.29 | |
2022-03-31 | -64.55 | -68.83 | |
2021-12-31 | -67.15 | -83.75 | |
2021-09-30 | -50.76 | -82.68 | |
2021-06-30 | -40.21 | -77.06 | |
2021-03-31 | -30.71 | -63.66 | |
2020-12-31 | -7.05 | -28.17 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -1.75 | -1.75 |
2024-12-31 | -1.97 | |
2024-09-30 | -2.33 | -2.33 |
2024-06-30 | -2.74 | -2.74 |
2024-03-31 | -3.23 | -3.23 |
2023-12-31 | -3.30 | |
2023-09-30 | -3.13 | -3.13 |
2023-06-30 | -2.81 | -2.81 |
2023-03-31 | -2.30 | -2.30 |
2022-12-31 | -2.07 | |
2022-09-30 | -1.87 | -1.87 |
2022-06-30 | -2.00 | -2.00 |
2022-03-31 | -2.77 | -2.77 |
2021-12-31 | -6.65 | |
2021-09-30 | -27.46 | -27.46 |
2021-06-30 | -30.74 | -30.74 |
2021-03-31 | -30.43 | -30.43 |
2020-12-31 | -14.17 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Ventyx Biosciences, Inc. per 2025 Jun 30 adalah -105.70 MM.
- Nilai cash from investing activities untuk Ventyx Biosciences, Inc. per 2025 Jun 30 adalah 69.86 MM.
- Nilai kas dari aktivitas pendanaan untuk Ventyx Biosciences, Inc. per 2025 Jun 30 adalah 26.91 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -105.70 | 69.86 | 26.91 |
2025-03-31 | -108.97 | -30.86 | 25.93 |
2024-12-31 | -130.87 | -15.51 | 122.11 |
2024-09-30 | -159.28 | 41.62 | 122.72 |
2024-06-30 | -158.48 | 51.26 | 97.49 |
2024-03-31 | -183.23 | 161.60 | 100.87 |
2023-12-31 | -166.52 | 100.94 | 53.33 |
2023-09-30 | -162.13 | -86.03 | 42.39 |
2023-06-30 | -151.46 | -60.75 | 218.56 |
2023-03-31 | -116.97 | -77.32 | 216.33 |
2022-12-31 | -98.77 | -74.93 | 167.77 |
2022-09-30 | -66.19 | -77.18 | 337.71 |
2022-06-30 | -53.25 | -214.51 | 210.30 |
2022-03-31 | -48.36 | -232.77 | 266.77 |
2021-12-31 | -38.65 | -214.37 | 323.55 |
2021-09-30 | -25.85 | -71.28 | 166.05 |
2021-06-30 | -16.69 | 1.89 | 117.57 |
2021-03-31 | -8.00 | 1.90 | 61.92 |
2020-12-31 | -6.20 | 6.13 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Ventyx Biosciences, Inc. pada 2025 Jun 30 adalah 0.65.
- p/tbv untuk Ventyx Biosciences, Inc. pada 2025 Jun 30 adalah 0.65.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 0.65 | 0.65 | |
2025-03-31 | -0.64 | 0.34 | 0.34 |
2024-12-31 | 0.57 | 0.57 | |
2024-09-30 | -0.95 | 0.58 | 0.58 |
2024-06-30 | -0.87 | 0.55 | 0.55 |
2024-03-31 | -2.12 | 1.68 | 1.68 |
2023-12-31 | -0.80 | 0.51 | 0.51 |
2023-09-30 | -12.95 | 6.24 | 6.24 |
2023-06-30 | -15.18 | 5.09 | 5.09 |
2023-03-31 | -17.96 | 5.50 | |
2022-12-31 | 7.64 | 7.64 | |
2022-09-30 | 8.12 | 8.12 | |
2022-06-30 | -9.02 | 2.40 | 2.40 |
2022-03-31 | -8.23 | 5.04 | 5.04 |
2021-12-31 | -12.07 | 10.20 | 10.20 |
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Ventyx Biosciences, Inc. pada 2025 Jun 30 adalah -1.00.
- EBIT (3 tahun) / EV untuk Ventyx Biosciences, Inc. pada 2025 Jun 30 adalah -1.22.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -1.00 | -1.22 |
2025-03-31 | -2.30 | -2.56 |
2024-12-31 | -1.59 | -1.58 |
2024-09-30 | -1.40 | -1.21 |
2024-06-30 | -7.25 | -4.84 |
2024-03-31 | -0.54 | -0.36 |
2023-12-31 | -2.03 | -1.33 |
2023-09-30 | -0.08 | -0.05 |
2023-06-30 | -0.07 | -0.05 |
2023-03-31 | -0.06 | -0.04 |
2022-12-31 | -0.06 | -0.04 |
2022-09-30 | -0.04 | -0.03 |
2022-06-30 | -0.09 | -0.06 |
2022-03-31 | -0.10 | -0.06 |
2021-12-31 | -0.07 | -0.03 |
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 |
Efektivitas Manajemen
- roa untuk Ventyx Biosciences, Inc. pada 2025 Jun 30 adalah -0.40.
- roe untuk Ventyx Biosciences, Inc. pada 2025 Jun 30 adalah -0.44.
- roic untuk Ventyx Biosciences, Inc. pada 2025 Jun 30 adalah -0.51.
- croic untuk Ventyx Biosciences, Inc. pada 2025 Jun 30 adalah -0.47.
- ocroic untuk Ventyx Biosciences, Inc. pada 2025 Jun 30 adalah -0.45.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.40 | -0.44 | -0.51 | -0.47 | -0.45 |
2025-03-31 | -0.41 | -0.44 | -0.51 | -0.09 | -0.49 |
2024-12-31 | -0.55 | -0.63 | -0.53 | 0.02 | -0.55 |
2024-09-30 | -0.53 | -0.60 | -0.59 | -0.03 | -0.54 |
2024-06-30 | -0.49 | -0.52 | -0.60 | 0.25 | -0.58 |
2024-03-31 | -0.52 | -0.55 | -0.75 | -0.05 | -0.65 |
2023-12-31 | -0.43 | -0.75 | -0.61 | -0.69 | -0.55 |
2023-09-30 | -0.60 | -0.65 | -0.48 | 0.02 | -0.46 |
2023-06-30 | -0.48 | -0.51 | -0.48 | 0.02 | -0.46 |
2023-03-31 | -0.39 | -0.42 | -0.33 | 0.06 | -0.31 |
2022-12-31 | -0.61 | -0.66 | -0.37 | 0.79 | -0.27 |
2022-09-30 | -0.49 | -0.75 | -0.37 | 0.79 | -0.27 |
2022-06-30 | -0.65 | -0.70 | -0.30 | -0.23 | -0.22 |
2022-03-31 | -0.79 | -0.86 | -0.26 | -0.05 | -0.19 |
2021-12-31 | -337.47 | -0.61 | 0.52 | -0.26 | |
2021-09-30 | -0.60 | ||||
2021-06-30 | -220.81 | -0.70 | 0.93 | -0.15 | |
2021-03-31 | -150.77 | -0.10 | |||
2020-12-31 | -80.73 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1851194 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |